Feb 2, 2009 - Acorda Therapeutics, Inc. today announced the submission of a New Drug Application to the U.S. FDA on January 30, 2009 for Fampridine-SR, a novel therapy being developed to improve walking ability in people with multiple sclerosis (MS).
The details can be read here.
No comments:
Post a Comment